Literature DB >> 2302836

Cross-reactive rheumatoid factors in rheumatoid arthritis with extra-articular disease.

M Kinoshita1, S Aotsuka, R Yokohari.   

Abstract

Rheumatoid factors (RF) have been shown to have considerable heterogeneity and bind with IgG as well as with a variety of substances such as nuclear histone, non-histone nuclear protein, nitrophenyl groups or ssDNA. We describe evidence that polyclonal RF cross-reactive with ssDNA (CRRF) are widely distributed in a variety of rheumatic diseases, and that their serum level is significantly higher in rheumatoid arthritis (RA) with extra-articular disease. Although the mechanism of the cross-reactivity is not clear, the presence of CRRF could be a serological feature of a clinical subset of RA. The high prevalence rate of CRRF in RA with extra-articular disease also suggests its pathogenetic role in the extra-articular manifestation of this disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302836      PMCID: PMC1534729          DOI: 10.1111/j.1365-2249.1990.tb05129.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

Review 1.  Origins of anti-DNA autoantibodies.

Authors:  R S Schwartz; B D Stollar
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

2.  Monocyte-mediated suppression of rheumatoid factor production in normal subjects.

Authors:  M Okawa-Takatsuji; S Aotsuka; S Uwatoko; R Yokohari; K Inagaki
Journal:  Clin Immunol Immunopathol       Date:  1988-02

3.  Idiotypic and genetic studies of human rheumatoid factors.

Authors:  D A Carson; P P Chen; T J Kipps; V Radoux; F R Jirik; R D Goldfien; R I Fox; G J Silverman; S Fong
Journal:  Arthritis Rheum       Date:  1987-12

4.  Characterisation of non-histone nuclear proteins cross reactive with purified rheumatoid factors.

Authors:  J C Mason; P J Venables; P R Smith; R N Maini
Journal:  Ann Rheum Dis       Date:  1985-05       Impact factor: 19.103

5.  An immunohistological study of secondary Sjögren's syndrome.

Authors:  D A Isenberg; D Rowe; A Tookman; A Hopp; M Griffiths; E Paice; J Stewart; P C Beverley
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

6.  Human-human hybridoma autoantibodies with both anti-DNA and rheumatoid factor activities.

Authors:  J Rauch; H Tannenbaum; K Straaton; H Massicotte; J Wild
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

7.  Naturally occurring antibodies to poly(ADP-ribose) in autoimmune MRL/Mp-lpr/lpr mice.

Authors:  Y Kanai; M Fujiwara
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

8.  Murine polyspecific antibodies. I. Monoclonal and serum anti-DNA antibodies cross-reactive with 2,4,6-trinitrophenyl derivatives.

Authors:  D Serban; C Rordorf-Adam; Y Z Sun; J Gordon
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

9.  Binding of isolated rheumatoid factors to histone proteins and basic polycations.

Authors:  R N Hobbs; D J Lea; K K Phua; P M Johnson
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

10.  Idiotypic cross-reactions of monoclonal human lupus autoantibodies.

Authors:  Y Shoenfeld; D A Isenberg; J Rauch; M P Madaio; B D Stollar; R S Schwartz
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  1 in total

1.  Extra-articular manifestations of rheumatoid arthritis: a hospital-based study.

Authors:  Aisha Al-Ghamdi; Suzan M Attar
Journal:  Ann Saudi Med       Date:  2009 May-Jun       Impact factor: 1.526

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.